Reyataz
Product Images NDC 69189-3624

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 69189-3624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atazanavir 150 mg Capsule (6918936241)

Packaging label of REYATAZ (Atazanavir) 150 mg capsule showing drug name, strength, dosage form, manufacturer as E.R. Squibb, and an expiration date of 3/31/16. The label includes product codes and a small QR code on the lower right.*

FDA Label Image

Reyataz Chemical Structure (Image 01)

Chemical structure of the active ingredient in REYATAZ, depicting its molecular arrangement including aromatic rings, amide groups, and sulfate.*

FDA Label Image

Reyataz Fig 1 (Reyataz Figure1)

A pharmacokinetic curve showing atazanavir plasma concentration (ng/mL) over time (hours) for two dosing regimens: ATV 400 mg and ATV/RTV 300/100 mg. Data points include error bars, with sample sizes noted (n=10 for ATV 400 mg and n=13 for ATV/RTV 300/100 mg). The graph highlights a median wild-type EC50 value of 14 ng/mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.